Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Arriaga

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Medical Primatology|July 1, 2015
Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) modelPatrice A Frost, Shuyuan Chen, Marguerite J Mezzles, et al.
Gynecologic Oncology|April 3, 2019
The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort studyMaarit A Laaksonen, Maria E Arriaga, Karen Canfell, et al.
International Journal of Epidemiology|July 9, 2018
The future burden of lung cancer attributable to current modifiable behaviours: a pooled study of seven Australian cohortsMaarit A Laaksonen, Karen Canfell, Robert MacInnis, et al.
BMJ Open|June 16, 2017
The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortiumMaria E Arriaga, Claire M Vajdic, Karen Canfell, et al.
International Journal of Cancer|February 26, 2019
The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort studyMaria E Arriaga, Claire M Vajdic, Karen Canfell, et al.
The Medical Journal of Australia|January 19, 2019
The burden of pancreatic cancer in Australia attributable to smokingMaria E Arriaga, Claire M Vajdic, Robert J MacInnis, et al.
JNCI Cancer Spectrum|July 31, 2019
The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort StudyClaire M Vajdic, Robert J MacInnis, Karen Canfell, et al.
The Oncologist|September 8, 2018
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN StudyEric Van Cutsem, Erika Martinelli, Stefano Cascinu, et al.
Global Health Action|October 27, 2023
Neonatal outcomes according to different degrees of maternal morbidity: cross-sectional evidence from the Perinatal Information System (SIP) of the CLAP networkMercedes Colomar, Bremen de Mucio, Claudio Sosa, et al.
BMC Pregnancy and Childbirth|August 24, 2023
The impact of maternal morbidity on cesarean section rates: exploring a Latin American network of sentinel facilities using the Robson's Ten Group Classification SystemClaudio Sosa, Bremen de Mucio, Mercedes Colomar, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Medical Primatology|July 1, 2015
Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) modelPatrice A Frost, Shuyuan Chen, Marguerite J Mezzles, et al.
Gynecologic Oncology|April 3, 2019
The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort studyMaarit A Laaksonen, Maria E Arriaga, Karen Canfell, et al.
International Journal of Epidemiology|July 9, 2018
The future burden of lung cancer attributable to current modifiable behaviours: a pooled study of seven Australian cohortsMaarit A Laaksonen, Karen Canfell, Robert MacInnis, et al.
BMJ Open|June 16, 2017
The burden of cancer attributable to modifiable risk factors: the Australian cancer-PAF cohort consortiumMaria E Arriaga, Claire M Vajdic, Karen Canfell, et al.
International Journal of Cancer|February 26, 2019
The preventable burden of breast cancers for premenopausal and postmenopausal women in Australia: A pooled cohort studyMaria E Arriaga, Claire M Vajdic, Karen Canfell, et al.
The Medical Journal of Australia|January 19, 2019
The burden of pancreatic cancer in Australia attributable to smokingMaria E Arriaga, Claire M Vajdic, Robert J MacInnis, et al.
JNCI Cancer Spectrum|July 31, 2019
The Future Colorectal Cancer Burden Attributable to Modifiable Behaviors: A Pooled Cohort StudyClaire M Vajdic, Robert J MacInnis, Karen Canfell, et al.
The Oncologist|September 8, 2018
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN StudyEric Van Cutsem, Erika Martinelli, Stefano Cascinu, et al.
Global Health Action|October 27, 2023
Neonatal outcomes according to different degrees of maternal morbidity: cross-sectional evidence from the Perinatal Information System (SIP) of the CLAP networkMercedes Colomar, Bremen de Mucio, Claudio Sosa, et al.
BMC Pregnancy and Childbirth|August 24, 2023
The impact of maternal morbidity on cesarean section rates: exploring a Latin American network of sentinel facilities using the Robson's Ten Group Classification SystemClaudio Sosa, Bremen de Mucio, Mercedes Colomar, et al.
Pageof 6